Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from DDRS: Detection of drug response SNPs specifically in patients receiving drug treatment. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research
10.1097/00008571-199808000-00001 · 1998 · External reference
10.1038/35103535
10.1038/35103535 · External reference
Pharmacogenomics–drug disposition, drug targets, and side effects
10.1056/nejmra020526 · 2003 · External reference
10.1200/jco.2001.19.8.2293
10.1200/jco.2001.19.8.2293 · External reference
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy
10.1038/sj.tpj.6500012 · 2001 · External reference
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
10.1038/sj.tpj.6500072 · 2002 · External reference
Polymorphism at 19q13.41 predicts breast cancer survival specifically after endocrine therapy
10.1158/1078-0432.ccr-15-0296 · 2015 · External reference
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
10.1172/jci.insight.137571 · 2020 · External reference
Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials
10.1097/ppo.0b013e3181bdc2e0 · 2009 · External reference
Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine
10.1038/nrd.2016.234 · 2017 · External reference
10.1158/1078-0432.ccr-11-1387
10.1158/1078-0432.ccr-11-1387 · External reference
Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
2013 · External reference
10.18637/jss.v040.i12
10.18637/jss.v040.i12 · External reference
10.1101/gr.226019.117
10.1101/gr.226019.117 · External reference
10.1038/nmeth.1923
10.1038/nmeth.1923 · External reference
10.1186/gb-2008-9-9-r137
10.1186/gb-2008-9-9-r137 · External reference
10.1158/0008-5472.can-17-0327
10.1158/0008-5472.can-17-0327 · External reference
10.1093/bib/bbs038
10.1093/bib/bbs038 · External reference
10.1093/bioinformatics/btu655
10.1093/bioinformatics/btu655 · External reference
10.1186/1471-2105-12-323
10.1186/1471-2105-12-323 · External reference
10.1038/nbt.2203
10.1038/nbt.2203 · External reference
10.1016/j.cell.2012.12.034
10.1016/j.cell.2012.12.034 · External reference
10.1038/ng1847
10.1038/ng1847 · External reference
10.1371/journal.pcbi.1000770
10.1371/journal.pcbi.1000770 · External reference
10.1093/bioinformatics/bts163
10.1093/bioinformatics/bts163 · External reference
DrugBank 5.0: a major update to the DrugBank database for 2018
2017 · External reference
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
2020 · External reference
STITCH: interaction networks of chemicals and proteins
10.1093/nar/gkm795 · 2008 · External reference
10.1038/s41467-019-09186-x
10.1038/s41467-019-09186-x · External reference
10.1073/pnas.0506580102
10.1073/pnas.0506580102 · External reference
Predict drug sensitivity of cancer cells with pathway activity inference
10.1186/s12920-018-0449-4 · 2019 · External reference
10.3390/cells8091034
10.3390/cells8091034 · External reference
Is H3K4me1 at enhancers correlative or causative?
10.1038/s41588-017-0018-3 · 2018 · External reference
Unresolved reference
External reference
10.1101/gr.122382.111
10.1101/gr.122382.111 · External reference
10.1038/ncb1712
10.1038/ncb1712 · External reference
Identification of personalized chemoresistance genes in subtypes of basal-like breast cancer based on functional differences using pathway analysis
10.1371/journal.pone.0131183 · 2015 · External reference
10.1007/s10549-011-1935-y
10.1007/s10549-011-1935-y · External reference
Chemical reactivity window determines prodrug efficiency toward glutathione transferase overexpressing cancer cells
10.1021/acs.molpharmaceut.6b00140 · 2016 · External reference
10.3892/etm.2017.4663
10.3892/etm.2017.4663 · External reference
10.1093/annonc/mdr483
10.1093/annonc/mdr483 · External reference
10.1161/jaha.115.002383
10.1161/jaha.115.002383 · External reference
